nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A B-cell–associated gene signature classification of diffuse large B-cell lymphoma by NanoString technology
|
Michaelsen, Thomas Yssing |
|
|
2 |
13 |
p. 1542-1546 |
artikel |
2 |
Allogeneic transplantation using TLI-ATG conditioning for Hodgkin lymphoma after failure of autologous transplantation
|
Spinner, Michael A. |
|
|
2 |
13 |
p. 1547-1550 |
artikel |
3 |
Analysis of carfilzomib cardiovascular safety profile across relapsed and/or refractory multiple myeloma clinical trials
|
Chari, Ajai |
|
|
2 |
13 |
p. 1633-1644 |
artikel |
4 |
Calcium-RasGRP2-Rap1 signaling mediates CD38-induced migration of chronic lymphocytic leukemia cells
|
Mele, Silvia |
|
|
2 |
13 |
p. 1551-1561 |
artikel |
5 |
Cheng MP, Pandit A, Antin JH, et al. Safety and immunogenicity of conjugate quadrivalent meningococcal vaccination after hematopoietic cell transplantation. Blood Adv. 2018;2(11):1272-1276.
|
|
|
|
2 |
13 |
p. 1541 |
artikel |
6 |
Editorial Board
|
|
|
|
2 |
13 |
p. i |
artikel |
7 |
Evolution of a chemosensitive core-binding factor AML into an aggressive leukemia with eosinophilic differentiation
|
Xiao, Wenbin |
|
|
2 |
13 |
p. 1517-1521 |
artikel |
8 |
Exposure-adjusted adverse events comparing blinatumomab with chemotherapy in advanced acute lymphoblastic leukemia
|
Stein, Anthony S. |
|
|
2 |
13 |
p. 1522-1531 |
artikel |
9 |
Gastrointestinal microbiota contributes to the development of murine transfusion-related acute lung injury
|
Kapur, Rick |
|
|
2 |
13 |
p. 1651-1663 |
artikel |
10 |
Human adult HSCs can be discriminated from lineage-committed HPCs by the expression of endomucin
|
Reckzeh, Kristian |
|
|
2 |
13 |
p. 1628-1632 |
artikel |
11 |
Impact of post-ASCT maintenance therapy on outcomes in patients with newly diagnosed multiple myeloma in Connect MM
|
Jagannath, Sundar |
|
|
2 |
13 |
p. 1608-1615 |
artikel |
12 |
Low-dose cytarabine to prevent myeloid leukemia in children with Down syndrome: TMD Prevention 2007 study
|
Flasinski, Marius |
|
|
2 |
13 |
p. 1532-1540 |
artikel |
13 |
Partial trisomy 21 contributes to T-cell malignancies induced by JAK3-activating mutations in murine models
|
Rivera-Munoz, Paola |
|
|
2 |
13 |
p. 1616-1627 |
artikel |
14 |
Phase 1 investigation of lenalidomide/rituximab plus outcomes of lenalidomide maintenance in relapsed CNS lymphoma
|
Rubenstein, James L. |
|
|
2 |
13 |
p. 1595-1607 |
artikel |
15 |
Telomere shortening correlates with leukemic stem cell burden at diagnosis of chronic myeloid leukemia
|
Bouillon, Anne-Sophie |
|
|
2 |
13 |
p. 1572-1579 |
artikel |
16 |
Ten-year outcome of patients with acute myeloid leukemia not treated with allogeneic transplantation in first complete remission
|
Vasu, Sumithira |
|
|
2 |
13 |
p. 1645-1650 |
artikel |
17 |
The common VWF single nucleotide variants c.2365A>G and c.2385T>C modify VWF biosynthesis and clearance
|
Mufti, Ahmad H. |
|
|
2 |
13 |
p. 1585-1594 |
artikel |
18 |
Trispecific killer engager CD16xIL15xCD33 potently induces NK cell activation and cytotoxicity against neoplastic mast cells
|
Don Yun, Hyun |
|
|
2 |
13 |
p. 1580-1584 |
artikel |
19 |
Up-front rituximab maintenance improves outcome in patients with follicular lymphoma: a collaborative Nordic study
|
Madsen, C. |
|
|
2 |
13 |
p. 1562-1571 |
artikel |